Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1981 Oct 15;125(8):857–859.

Recognizing hyperparathyroidism caused by ectopic production of a substance resembling parathyroid hormone.

P Ernst, M Kaye
PMCID: PMC1862707  PMID: 7306896

Full text

PDF
857

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benson R. C., Jr, Riggs B. L., Pickard B. M., Arnaud C. D. Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med. 1974 Jun;56(6):821–826. doi: 10.1016/0002-9343(74)90810-9. [DOI] [PubMed] [Google Scholar]
  2. Buckle R. Ectopic PTH syndrome, pseudohyperparathyroidism; hypercalcaemia of malignancy. Clin Endocrinol Metab. 1974 Jul;3(2):237–251. doi: 10.1016/s0300-595x(74)80008-3. [DOI] [PubMed] [Google Scholar]
  3. Clinicopathologic conference. Malignant hypercalcemia. Am J Med. 1979 Sep;67(3):486–494. [PubMed] [Google Scholar]
  4. Demers L. M., Allegra J. C., Harvey H. A., Lipton A., Luderer J. R., Mortel R., Brenner D. E. Plasma prostaglandins in hypercalcemic patients with neoplastic disease. Cancer. 1977 Apr;39(4):1559–1562. doi: 10.1002/1097-0142(197704)39:4<1559::aid-cncr2820390430>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  5. Gray R. W., Wilz D. R., Caldas A. E., Lemann J., Jr The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 1977 Aug;45(2):299–306. doi: 10.1210/jcem-45-2-299. [DOI] [PubMed] [Google Scholar]
  6. Heath D. A. Hypercalcaemia and malignancy. Ann Clin Biochem. 1976 Nov;13(6):555–560. doi: 10.1177/000456327601300159. [DOI] [PubMed] [Google Scholar]
  7. Lafferty F. W. Pseudohyperparathyroidism. Medicine (Baltimore) 1966 May;45(3):247–260. doi: 10.1097/00005792-196605000-00004. [DOI] [PubMed] [Google Scholar]
  8. Mundy G. R., Raisz L. G., Cooper R. A., Schechter G. P., Salmon S. E. Evidence for the secretion of an osteoclast stimulating factor in myeloma. N Engl J Med. 1974 Nov 14;291(20):1041–1046. doi: 10.1056/NEJM197411142912001. [DOI] [PubMed] [Google Scholar]
  9. Potts J. T., Jr, Niall H. D., Tregear G. W., van Rietschoten J., Habener J. F., Segre G. V., Keutmann H. T. Chemical and biologic studies of proparathyroid hormone and parathyroid hormone: analysis of hormone biosynthesis and metabolism. Mt Sinai J Med. 1973 May-Jun;40(3):448–461. [PubMed] [Google Scholar]
  10. Raisz L. G., Yajnik C. H., Bockman R. S., Bower B. F. Comparison of commercially available parathyroid hormone immunoassays in the differential diagnosis of hypercalcemia due to primary hyperparathyroidism or malignancy. Ann Intern Med. 1979 Nov;91(5):739–740. doi: 10.7326/0003-4819-91-5-739. [DOI] [PubMed] [Google Scholar]
  11. Riggs B. L., Arnaud C. D., Reynolds J. C., Smith L. H. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest. 1971 Oct;50(10):2079–2083. doi: 10.1172/JCI106701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shaw J. W., Oldham S. B., Rosoff L., Bethune J. E., Fichman M. P. Urinary cyclic AMP analyzed as a function of the serum calcium and parathyroid hormone in the idfferential diagnosis of hypercalcemia. J Clin Invest. 1977 Jan;59(1):14–21. doi: 10.1172/JCI108611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Skrabanek P., McPartlin J., Powell D. Tumor hypercalcemia and "ectopic hyperparathyroidism". Medicine (Baltimore) 1980 Jul;59(4):262–282. doi: 10.1097/00005792-198007000-00003. [DOI] [PubMed] [Google Scholar]
  14. TASHJIAN A. H., Jr, LEVINE L., MUNSON P. L. IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA. J Exp Med. 1964 Mar 1;119:467–484. doi: 10.1084/jem.119.3.467. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES